All Stocks
M

MLTX

MoonLake Immunotherapeutics
Healthcare›Biotechnology|NASDAQ Capital Market|CH

Price

$17.36

Market Cap

$1.25B

Beta

1.19

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)-86.77%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio—
FCF Yield-15.74%
Debt / Equity0.25
Interest Coverage-33.8x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for MLTX.